Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

December 7, 2025

  • Autoimmune Diseases
    Autoimmune Diseases

    Autoimmune disease is when the immune system mistakenly attacks the body's tissues, often linked to imbalances in the microbiome, which can disrupt immune regulation and contribute to disease development.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-12-07

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This review focuses on the environmental risk factors associated with the development of inflammatory bowel disease (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC). It explores the complex interplay between environmental exposures, microbiome alterations, and immune responses that contribute to the onset and progression of IBD. The review synthesizes findings from various meta-analyses, highlighting modifiable risk factors such as smoking, diet, and early-life antibiotic use, while also discussing protective factors like breastfeeding and Mediterranean diets. It aims to provide a strategy for reducing IBD risk through environmental modifications and guides healthcare providers on preventing IBD through lifestyle changes.

Who was studied?

This review does not focus on a specific patient group but instead synthesizes data from multiple studies involving a wide range of populations across different age groups and ethnic backgrounds. It includes studies from both high-prevalence and newly industrialized regions, focusing on individuals who have been exposed to various environmental factors and assessing how these exposures influence the likelihood of developing CD and UC. The review also examines preclinical cohorts, including those at high genetic risk for IBD, to identify potential biomarkers and environmental factors that may trigger disease onset.

Most important findings

The review identifies several environmental factors that contribute to the pathogenesis of IBD. Smoking is a significant risk factor, especially for Crohn’s disease, and has been shown to worsen disease progression. In contrast, a Mediterranean diet rich in fiber, fruits, vegetables, and fish has a protective effect, potentially reducing inflammation and modulating the gut microbiome. Early life exposures, such as antibiotic use and breastfeeding, play crucial roles in shaping the gut microbiota, with breastfeeding being protective against IBD. The review highlights the Hygiene Hypothesis, which suggests that a lack of early exposure to microbes in sterile environments increases the risk of immune-mediated diseases like IBD. Lifestyle factors such as physical activity, stress management, and maintaining a healthy weight are associated with a lower risk of IBD.

Key implications

The findings suggest that modifiable environmental factors present an opportunity for preventive health strategies aimed at reducing the incidence of IBD. Healthcare providers can play a pivotal role in advising patients on lifestyle and dietary changes that can mitigate the risk of developing IBD. The review also stresses the importance of future research to develop high-quality interventional studies that can more definitively assess the effectiveness of environmental modifications in preventing IBD. Identifying biomarkers associated with ecological exposures will further help in targeting high-risk individuals for early interventions. In particular, the review calls for more comprehensive studies involving diverse populations to understand the varying effects of environmental factors on IBD risk across different regions and demographics.

Crohn’s Disease

Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract that can cause a wide range of symptoms, including abdominal pain, diarrhea, and fatigue. The exact cause of the disease remains unclear, but it is believed to result from a combination of genetic predisposition and environmental factors. Although there is no cure, ongoing advancements in medical research continue to improve management strategies and quality of life for those affected by Crohn's disease.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.